SecBot SecBot
Insider Cluster (3 insiders) ·Filed Mar 26, 2026

NUVL

Nuvalent, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.7M total
Actionable Insight • Neutral

The sales are small relative to company size and likely represent routine post-exercise diversification; monitor for recurrence or larger-scale selling. No immediate red flags, but watch for absence of insider buying ahead of next earnings or catalyst.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$96.66
T+0 close · Mar 26, 2026 · via day close
Latest settled
+27.85%
T+60 · $123.58
Vs SPY
+12.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 27 $96.66entry
  2. T+1 · 8mo ago +0.06%α +0.40% · $96.72
  3. T+5 · 8mo ago +7.29%α +3.38% · $103.71
  4. T+20 · 7mo ago +7.63%α −5.15% · $104.04
  5. T+60 · 5mo ago +27.85%α +12.21% · $123.58
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Nuvalent executives, including the CFO and Chief Development Officer, sold shares in a coordinated cluster totaling $708K over a 7-day window. The sales represent a modest 0.0085% of the company's $8.3B market cap and appear tied to option exercises, with no open-market buying observed.

Key Financial Metrics

Direction
selling
Total Value
$708.0K
Insiders
3

Key Facts

  • CFO Alexandra Balcom sold $370K in shares, following derivative exercises of over 22K shares (mostly non-cash).
  • Chief Development Officer Darlene Noci sold $247K in shares, concurrent with exercising 11K options.
  • Chief Legal Officer Deborah Miller sold $92K in shares, completing the cluster.
  • Total open-market sales: $708K across 3 C-suite insiders; no open-market purchases detected.
  • All transactions occurred between March 26 and April 1, 2026.

Financial Impact

$708,000 in insider sales over 7 days (0.0085% of $8.3B market cap)

insider ownershipmarket sentiment

Risk Factors

  • Perception of insider pessimism if sales continue in next quarter.
  • Concentration of selling among C-suite executives, though not material in dollar size.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NUVL-1775248264993

US Market Status

Market Closed · Opens Wed (11h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026